logo

Edelweiss MSCI India D&W HC 45 RegIDCW-P

0

0.00(0%)
NAV as of . Log in to view Live prices
Open Free Demat Account

By signing up I certify terms, conditions & privacy policy

Scheme Information

Logo

Edelweiss MSCI India D&W HC 45 RegIDCW-P

as of 05 Jul 2026, 12:16 PM

Scheme Asset Size₹174.93 Cr
Expense Ratio1.06%
Cash Holding0.32093%
Fund TypeOpen-End
PlanDividend
BenchmarkMSCI Ind Dom & Wld HealthC 45 NR INR
Launch Date2020-10-26
Exit LoadExit load of 0.00% for investments if redeemed within 1 Months

SIP Calculator

12%
₹5,000
₹500₹10,00,000
10 Years
1 Year40 Years
Invested Amount
Estimated Return

Invested Amount

₹6,00,000

Est. Return

₹5,61,695

Total Value

₹11,61,695

Invested Amount
Estimated Return
Invest Now

Scheme Ratings

-

rated by Value Research

Scheme Riskometer

Your principal will be at Very High Risk

Investment Returns

Absolute Returns

CAGR

In the last 1 months -4.78%
In the last 3 months -3.89%
In the last 6 months 1.15%
In the last 1 Years 3.82%
In the last 3 Years 0.75%
In the last 5 Years 0.90%

Company Holdings

Company Name
Sector
Instrument
Assets
Sun Pharmaceuticals Industries LtdHealthcareE11.25%
Eli Lilly and CoHealthcareE6.01%
Max Healthcare Institute Ltd Ordinary SharesHealthcareE5.73%
Apollo Hospitals Enterprise LtdHealthcareE5.69%
Divi's Laboratories LtdHealthcareE5.17%
Cipla LtdHealthcareE5.14%
Dr Reddy's Laboratories LtdHealthcareE4.71%
Johnson & JohnsonHealthcareE4.25%
Lupin LtdHealthcareE3.90%
Torrent Pharmaceuticals LtdHealthcareE3.46%
Fortis Healthcare LtdHealthcareE3.12%
AbbVie IncHealthcareE2.91%
Laurus Labs LtdHealthcareE2.55%
Novartis AG ADRHealthcareE2.28%
Glenmark Pharmaceuticals LtdHealthcareE2.24%
Merck & Co IncHealthcareE2.20%
Aurobindo Pharma LtdHealthcareE2.15%
Mankind Pharma LtdHealthcareE1.88%
Alkem Laboratories LtdHealthcareE1.82%
Amgen IncHealthcareE1.48%
Ipca Laboratories LtdHealthcareE1.44%
Abbott LaboratoriesHealthcareE1.42%
Biocon LtdHealthcareE1.41%
Thermo Fisher Scientific IncHealthcareE1.37%
Gilead Sciences IncHealthcareE1.31%
Intuitive Surgical IncHealthcareE1.27%
Zydus Lifesciences LtdHealthcareE1.25%
Aster DM Healthcare Ltd Ordinary SharesHealthcareE1.03%
Danaher CorpHealthcareE0.95%
Stryker CorpHealthcareE0.94%
Gland Pharma LtdHealthcareE0.91%
Vertex Pharmaceuticals IncHealthcareE0.90%
Medtronic PLCHealthcareE0.89%
Narayana Hrudayalaya LtdHealthcareE0.88%
Ajanta Pharma LtdHealthcareE0.88%
Novo Nordisk AS ADRHealthcareE0.86%
GlaxoSmithKline Pharmaceuticals LtdHealthcareE0.73%
Piramal Pharma LtdHealthcareE0.63%
Global Health LtdHealthcareE0.62%
Regeneron Pharmaceuticals IncHealthcareE0.58%
Syngene International LtdHealthcareE0.52%
Becton Dickinson & CoHealthcareE0.36%
Agilent Technologies IncHealthcareE0.24%
IQVIA Holdings IncHealthcareE0.21%
Illumina IncHealthcareE0.14%
Net Receivables/(Payables)-CA0.17%
Clearing Corporation Of India Ltd.-CR0.15%
Accrued Interest-CA0.00004%

Sector Holding Analysis

Equity / Debt / Cash Split

Loading chart…

Equity

99.68%

Cash

0.32%

Equity sector allocation

Loading chart…

Healthcare

99.68%

Others

0.32%

Fund House Contact Details

Websitewww.edelweissmf.com
Phone+91 22 40979900
Logo
Edelweiss Asset Management Limited

Asset Management Company

About Edelweiss MSCI India D&W HC 45 RegIDCW-P

Investment Objective of the Scheme

The Scheme will invest in stocks comprising of the MSCI India Domestic & World Healthcare 45 Index with the objective to provide investment returns that, before expenses, closely corresponds to the returns equivalent to the index, subject to tracking errors. However, there is no assurance that the investment objective of the Scheme will be realized and the Scheme does not assure or guarantee any returns.

Key Features of The Fund

5-year return

+13.64%

Fund Manager

Bhavesh Jain

Risk Profile

Very High Risk

Expense Ratio

1.06%

Fund Size

₹174.93 Cr

Edelweiss MSCI India D&W HC 45 RegIDCW-P Summary

Edelweiss MSCI India D&W HC 45 RegIDCW-P NAV, Returns, Performance & Details

Edelweiss MSCI India D&W HC 45 RegIDCW-P is currently priced at ₹20.29, as of 05 Jul 2026, 12:16 PM. The fund has recorded a change of ₹0.15 (0.73%), indicating its recent movement in the market.

Tracking NAV trends helps investors understand short-term price movement, while long-term performance gives a better picture of wealth creation potential.

Edelweiss MSCI India D&W HC 45 RegIDCW-P Fund Details and Key Information

Edelweiss MSCI India D&W HC 45 RegIDCW-P is an open-ended mutual fund that invests based on its stated objective and benchmark.

Key details:

  • Asset Size: ₹174.93 Cr

  • Expense Ratio: 1.06%

  • Cash Holding: 0.32%

  • Plan Type: Dividend

  • Benchmark: MSCI Ind Dom & Wld HealthC 45 NR INR

  • Launch Date: 2020-10-26

  • Exit Load: 0.00

These factors help investors evaluate cost, scale, and fund positioning before making an investment decision.

Edelweiss MSCI India D&W HC 45 RegIDCW-P Returns and Performance

Edelweiss MSCI India D&W HC 45 RegIDCW-P has delivered returns across multiple timeframes, reflecting its ability to perform across different market conditions.

Returns:

  • 1 Month: -4.78%

  • 3 Months: -3.89%

  • 6 Months: 1.15%

  • 1 Year: 3.82%

  • 3 Years: 0.75%

  • 5 Years: 0.90%

Short-term returns indicate recent momentum, while long-term returns show consistency and wealth creation ability.

Edelweiss MSCI India D&W HC 45 RegIDCW-P Risk Level and Volatility

Understanding risk is important before investing. Edelweiss MSCI India D&W HC 45 RegIDCW-P falls under: For investors in the 20–40 age group, selecting a fund with the right risk level is important based on financial goals, investment horizon, and comfort with market movements.

Risk Level: Very High Risk

The riskometer helps investors understand how stable or volatile the fund can be based on its investment strategy and asset allocation. Funds with higher risk levels may offer better return potential over time, but they can also experience sharper short-term fluctuations. This classification reflects the volatility associated with the fund. Higher risk funds may offer higher returns but come with greater fluctuations.

Edelweiss MSCI India D&W HC 45 RegIDCW-P Portfolio Allocation

The asset allocation of Edelweiss MSCI India D&W HC 45 RegIDCW-P shows how investments are distributed across asset classes.

  • Equity Allocation: 99.68%

  • Cash Allocation: 0.32%

This allocation plays a key role in determining the fund’s risk and return profile.

Edelweiss MSCI India D&W HC 45 RegIDCW-P Sector Allocation

Edelweiss MSCI India D&W HC 45 RegIDCW-P diversifies its investments across sectors to reduce risk.

Sector Holding Detail

  • Healthcare: 99.68%

Sector allocation data helps investors understand which industries the fund is focusing on.

Edelweiss MSCI India D&W HC 45 RegIDCW-P Fund House

Edelweiss MSCI India D&W HC 45 RegIDCW-P is managed by:

AMC Name: Edelweiss Asset Management Limited

A strong fund house with a proven track record can improve investor confidence.

Edelweiss MSCI India D&W HC 45 RegIDCW-P Minimum Investment

Investors can start investing in Edelweiss MSCI India D&W HC 45 RegIDCW-P with:

Minimum Investment: ₹100

This makes the fund accessible for both beginners and experienced investors.

FAQ's

Desktop BannerMobile Banner
Invest Anytime, Anywhere
Play StoreApp Store
Open Free Demat Account Online

By signing up I certify terms, conditions & privacy policy